Key facts

Active substance
N-hydroxy-5-methylfuran-2-sulfonamide (BMS-986231)
Therapeutic area
Cardiovascular diseases
Decision number
PIP number
Pharmaceutical form(s)
  • Powder for concentrate for solution for infusion
  • Age-appropriate dosage form for parenteral use
Condition(s) / indication(s)
Treatment of acute heart failure
Route(s) of administration
Intravenous use
Contact for public enquiries
Bristol-Myers Squibb International Corporation

Tel. +44 (0)1895 523740
E-mail: medical.information@bms.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)


How useful was this page?

Add your rating